Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits

Journal of Neurochemistry

Volumn 83, Issue 3, 2002, Pages 592-600

  Lawlor, Mike W ^b   Richards, Michael P ^a   De Vries, George H ^a,b   Fisher, Morris A ^a,b   Stubbs Jr , Evan B ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Antibody; Diabetes; MGUS; Neuropathy; Periaxin

Indexed keywords

AUTOANTIBODY; L PERIAXIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; MUSCLE ACTION POTENTIAL; NERVE FUNCTION; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION;

AGED; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; BLOOD PROTEINS; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; H-REFLEX; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEURAL CONDUCTION; PARAPROTEINEMIAS; PEPTIDE FRAGMENTS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED LEW; REFERENCE VALUES; SCIATIC NERVE;

ANIMALIA;

EID: 0036829266     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01159.x     Document Type: Article

References (47)

1. Adams R. D., Victor M. and Ropper A. H. (1997) Diseases of the peripheral nerves. In: Principles of Neurology (Wonsiewicz M. J. and Mavrozov M., eds), pp. 1302-1369. McGraw-Hill, New York.
2. van den Berg L., Hays A. P., Nobile-Orazio E., Kinsella L. J., Manfredini E., Corbo M., Rosoklija G., Younger D. S., Lovelace R. E., Trojaborg W., Lange D. E., Goldstein S., Delfiner J. S., Sadiq S. A., Sherman W. H. and Latov N. (1996) Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 19, 637-643.
3. Boerkoel C. F., Takashima H., Stankiewicz P., Garcia C. A., Leber S. M., Rhee-Morris L. and Lupski J. R. (2001) Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am. J. Hum. Genet. 68, 325-333.
4. Bomont P., Cavalier L., Blondeau F., Ben H. C., Belal S., Tazir M., Demir E., Topaloglu H., Korinthenberg R., Tuysuz B., Landrieu P., Hentati F. and Koenig M. (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 26, 370-374.
5. Braun P. E., Frail D. E. and Latov N. (1981) Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J. Neurochem. 39, 1261-1265.
6. Braxton D. B., Williams M., Kamali D., Chin S., Liem R. and Latov N. (1989) Specificity of human anti-neurofilament autoantibodies. J. Neuroimmunol. 21, 193-203.
7. Brindel I., Preud'homme J. L., Diaz J. J., Giraud C., Vallat J. M. and Jauberteau M. O. (1995) A human monoclonal IgM lambda-specific for an epitope shared by the 200-kDa neurofilament protein, histones and ribosomal proteins. J. Autoimmun. 8, 915-929.
8. Connolly A. M., Pestronk A., Trotter J. L., Feldman E. L., Cornblath D. R. and Olney R. K. (1993) High-titer selective serum anti-β-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 43, 557-562.
9. Corbo M. and Hays A. P. (1998) Immunopathological studies in immune-mediated neuropathies. In: Immunological and Infectious Diseases of the Peripheral Nerves (Latov N., Wokke J. H. J. and Kelly J. J. Jr, eds), 81-95. Cambrige University Press, Cambridge.
10. Dalakas M. C. and Engel W. K. (1981) Polyneuropathy with monoclonal gammopathy: Studies of 11 patients. Ann. Neurol. 10, 45-52.
11. Fabian R. H. (1988) Uptake of plasma IgG by CNS motorneurons: Comparison of antineuronal and normal IgG. Neurology 38, 1775-1780.
12. Fabian R. H. (1990) Uptake of antineuronal IgM by CNS neurons: Comparison with antineuronal IgG. Neurology 40, 419-422.
13. Fazio R., Nemni R., Quattrini A., Lorenzetti I. and Canal N. (1992) IgG monoclonal proteins from patients with axonal peripheral neuropathies bind to different epitopes of the 68-kDa neurofilament protein. J. Neuroimmunol. 36, 97-104.
14. Feirabend H. K., Choufoer H. and Ploeger S. (1998) Preservation and staining of myelinated nerve fibers. Methods 15, 123-131.
15. Gillespie C. S., Sherman D. L., Blair G. E. and Brophy P. J. (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12, 497-508.
16. Gillespie C. S., Sherman D. L., Fleetwood-Walker S. M., Cottrel D. F., Tait S., Garry E. M., Wallace V. C. J., Ure J., Giffiths I. R., Smith A. and Brophy P. J. (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26, 523-531.
17. Graus F., Elkon K. B., Cordon-Cardo C. and Posner J. B. (1986) Sensory neuronopathy and small cell lung cancer: An antineuronal antibody that also reacts with the tumor. Am. J. Med. 80, 45-52.
18. Guilbert B., Dighiero G. and Avrameas S. (1982) Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation, and characterization. J. Immunol. 128, 2779-2787.
19. Guilbot A., Williams A., Ravise N., Verny C., Brice A., Sherman D. L., Brophy P. J., LeGuern E., Delague V., Bareil C., Megarbane A. and Claustres M. (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 10, 415-421.
20. Hammer J. A., O'Shannessy D. J., De Leon M., Gould R., Zand D., Daune G. and Quarles R. H. (1993) Immunoreactivity of PMP-22, P0, and other 19-28-kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies. J. Neurosci. Res. 35, 546-558.
21. Hays A. P., Latov N., Takatsu M. and Sherman W. H. (1987) Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37, 242-256.
22. Ho T. W., McKhann G. M. and Griffin J. W. (1998) Human autoimmune neuropathies. Ann. Rev. Neurosci. 21, 187-226.
23. Ilyas A. A., Quarles R. H., Macintosh T. D., Dobersen M. J., Trapp B. D., Dalakas M. C. and Brady R. O. (1984) IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc. Natl. Acad. Sci. USA 81, 1225-1229.
24. Krendel D. A., Costigan D. A. and Hopkins L. C. (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch. Neurol. 52, 1053-1061.
25. Kruse J., Mailhammer R., Wernecke H., Faissner A., Sommer I., Goridis C. and Schachner M. (1984) Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature 311, 153-155.
26. Kyle R. A. (1992) Monoclonal proteins in neuropathy. Neurol. Clin. 10, 713-734.
27. Lawlor M. W., Richards M. P., Fisher M. A. and Stubbs E. B. Jr (2001) Sensory nerve conduction deficit in experimental monoclonal gammopathy of undetermined significance (MGUS) neuropathy. Muscle Nerve 24, 809-816.
28. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
29. Milicevic Z., Newlon P. G., Pittenger G. L., Stansberry K. B. and Vinik A. I. (1997) Anti-ganglioside GM1 antibody and distal symmetric 'diabetic polyneuropathy' with dominant motor features. Diabetologia 40, 1364-1365.
30. Moorhouse D. F., Fox R. L. and Powell H. C. (1992) Immunotactoid-like endoneurial deposits in a patient with monoclonal gammopathy of undetermined significance and neuropathy. Acta Neuropathol. (Berl) 84, 484-494.
31. Neuberger T. J. and De Vries G. H. (1993) Distribution of fibroblast growth factor in cultured dorsal root ganglion neurons and Schwann cells. I. Localization during maturation in vitro. J. Neurocytol. 22, 436-448.
32. Nobile-Orazio E., Manfredini E., Carpo M., Meucci N., Monaco S., Ferrari S., Bonetti B., Cavaletti G., Gemignani F., Durelli L., Barbieri S., Allaria S., Sgarzi M. and Scarlato G. (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann. Neurol. 36, 416-424.
33. Quarles R. H. and Weiss M. D. (1999) Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22, 800-822.
34. Ritchie T. C., Fabian R. H. and Coulter J. D. (1985) Axonal transport of antibodies to subcellular and protein fractions of rat brain. Brain Res. 343, 252-261.
35. Rosoklija G. B., Dwork A. J., Younger D. S., Karlikaya G., Latov N. and Hays A. P. (2000) Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Acta Neuropathol. 99, 55-62.
36. Said G., Goulon-Goeau C., Lacroix C. and Moulonguet A. (1994) Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann. Neurol. 35, 559-569.
37. Sewell H. G., Matthews J. B., Gooch E., Millac P., Willox A., Stern M. A. and Walker F. (1981) Autoantibody to nerve tissue in a patient with a peripheral neuropathy and an IgG paraprotein. J. Clin. Pathol. 34, 1163-1166.
38. Shibuya A., Sakamoto N., Shimizu Y., Shibuya K., Osawa M., Hiroyama T., Eyre H. J., Sutherland G. R., Endo Y., Fujita T., Miyabayashi T., Sakano S., Tsuji T., Nakayama E., Phillips J. H., Lanier L. L. and Nakauchi H. (2000) Fcx/μ receptor medicates endocytosis of IgM-coated microbes. Nature Immunol. 1, 441-446.
39. Shigeta H., Yamaguchi M., Nakano K., Obayashi H., Takemura R., Fukui M., Fujii M., Yoshimori K., Hasegawa G., Nakamura N., Kitagawa Y. and Kondo M. (1997) Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy. Diabetes Care 20, 1896-1899.
40. Shuman S., Hardy M. and Pleasure D. (1983) Peripheral nervous system myelin and Schwann cell glycoproteins: Identification by lectin binding and partial purification of a peripheral nervous system myelin-specific 170,000 molecular weight glycoprotein. J. Neurochem. 41, 1277-1285.
41. Stefansson K., Marton L. S., Dieperink M. E., Molnar G. K., Schlaepfer W. W. and Helgason C. M. (1985) Circulating autoantibodies to the 200 000-Dalton protein of neurofilaments in the serum of healthy individuals. Science 228, 1117-1119.
42. Stubbs E. B. Jr, Fisher M. A., Wilson J. R. and Siegel G. J. (1996) High-titer IgM antibody to nerve specific class III β-tubulin in the serum of a patient with sensory demyelinating polyneuropathy. Muscle Nerve 19, 1638-1639.
43. Stubbs E. B. Jr, Fisher M. A. and Siegel G. J. (1998) Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization. Acta Neuropathol. 95, 302-305.
44. Sun G. Y., Huan H.-M., Kelleher J. A., Stubbs E. B. Jr and Sun A. Y. (1988) Marker enzymes, phospholipids and acyl group composition of a somal plasma membrane fraction isolated from rat cerebral cortex: a comparison with microsomes and synaptic plasma membranes. Neurochem. Int. 12, 69-77.
45. Tatum A. H. (1993) Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann. Neurol. 33, 502-506.
46. Voshol H., van Zuylen C. W., Orberger G., Vliegenthart J. F. and Schachner M. (1996) Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein PO. J. Biol. Chem. 271, 22957-22960.
47. Weiss M. D., Dalakas M. C., Lauter C. J., Willison H. J. and Quarles R. H. (1999) Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in dymyelinating neuropathy and IgM parpaproteinemia. J. Neuroimmunol. 95, 174-184.